BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12192463)

  • 21. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasminogen activator inhibitor-1 mRNA expression by the iris and lens epithelial cells of rabbit eye with intraocular lens implantation].
    Wu Q; Yang G; Chen G; Dai Y
    Zhonghua Yan Ke Za Zhi; 1999 May; 35(3):223-6. PubMed ID: 11835812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candidate host marker for peritoneal dissemination.
    Hashizume K; Uchiyama A; Sasaki N; Noshiro H; Morisaki T; Tanaka M; Katano M
    Anticancer Res; 2002; 22(3):1781-6. PubMed ID: 12168869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
    Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
    Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astrocyte regulation of human brain capillary endothelial fibrinolysis.
    Kim JA; Tran ND; Wang SJ; Fisher MJ
    Thromb Res; 2003; 112(3):159-65. PubMed ID: 14967413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
    Liu JW; Wei DZ; Du CB; Zhong JJ
    Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer.
    Spyratos F; Bouchet C; Tozlu S; Labroquere M; Vignaud S; Becette V; Lidereau R; Bieche I
    Anticancer Res; 2002; 22(5):2997-3003. PubMed ID: 12530032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice.
    Tsujino T; Naito Y; Kawasaki D; Okuda S; Sakoda T; Fujioka Y; Sugaya T; Ohyanagi M
    Clin Exp Hypertens; 2005; 27(2-3):159-68. PubMed ID: 15835378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of human beta-defensins in intraocular tissues.
    Haynes RJ; McElveen JE; Dua HS; Tighe PJ; Liversidge J
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3026-31. PubMed ID: 10967060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nickel-induced plasminogen activator inhibitor-1 expression inhibits the fibrinolytic activity of human airway epithelial cells.
    Andrew A; Barchowsky A
    Toxicol Appl Pharmacol; 2000 Oct; 168(1):50-7. PubMed ID: 11000099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells.
    Hackett SF; Campochiaro PA
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):2055-61. PubMed ID: 8491554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expression.
    Lamy PJ; Verjat T; Servanton AC; Paye M; Leissner P; Mougin B
    Am J Clin Pathol; 2007 Sep; 128(3):404-13. PubMed ID: 17709314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue factor and plasminogen activator inhibitor type 2 expression in human stimulated monocytes is inhibited by heparin.
    Pepe G; Giusti B; Attanasio M; Gori AM; Comeglio P; Martini F; Gensini G; Abbate R; Neri Serneri GG
    Semin Thromb Hemost; 1997; 23(2):135-41. PubMed ID: 9200337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.
    Jaulmes A; Sansilvestri-Morel P; Rolland-Valognes G; Bernhardt F; Gaertner R; Lockhart BP; Cordi A; Wierzbicki M; Rupin A; Verbeuren TJ
    Thromb Res; 2009 Sep; 124(4):439-46. PubMed ID: 19540572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
    Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of plasminogen activator and inhibitor in the lymphatic endothelium.
    Leak LV; Saunders M; Day AA; Jones M
    Microvasc Res; 2000 Nov; 60(3):201-11. PubMed ID: 11078636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.